Cellular Therapy and Cord Blood 2013 Market Report
This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences.
In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.
We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, given our global footprint, we've been able to compare the EU and US markets side-by-side in this analysis.
Select Biosciences also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union. Details on the statute as well as implications to companies seeking to navigate this space are provided.
This Report is Written and Delivered to Customers in PowerPoint Format allowing convenient drag-and-drop for business plans, R&D presentations, investor presentations. Report purchasers receive full commercial rights to use the data and analyses presented in the report for their in-house business activities.
Extensive Market Analyses Presented in this Report:
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
Adult Stem Cell Therapy Quantitative Market Forecast
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
EU and US Cord Blood Transplantation Detailed Cost Breakouts
EU ATMP Regulation Detailed Analysis
Stem Cells Worldwide Publications Analysis
In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.
We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization. We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.
Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving. Our coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood. Furthermore, given our global footprint, we've been able to compare the EU and US markets side-by-side in this analysis.
Select Biosciences also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union. Details on the statute as well as implications to companies seeking to navigate this space are provided.
This Report is Written and Delivered to Customers in PowerPoint Format allowing convenient drag-and-drop for business plans, R&D presentations, investor presentations. Report purchasers receive full commercial rights to use the data and analyses presented in the report for their in-house business activities.
Extensive Market Analyses Presented in this Report:
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
Adult Stem Cell Therapy Quantitative Market Forecast
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
EU and US Cord Blood Transplantation Detailed Cost Breakouts
EU ATMP Regulation Detailed Analysis
Stem Cells Worldwide Publications Analysis
CHAPTER I. CELLULAR THERAPEUTICS MARKET LANDSCAPE
Stem Cell Market Segmentation and Industry Structure
Quantitative Trends in the Cellular Therapy and Regenerative Medicine Marketplace
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerativi Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT Market Timeline
Adult Stem Cell Therapy Quantitative Market Forecast
Stem Cell Research Workflow and Product Development Value Chain
Quantitative Scale of Cellular Therapy Market Opportunities in Various
Disease Classes
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell
Type, Therapeutic Areas Addressed, Geography
Companies and Marketed Cellular Therapy Products Currently
CHAPTER II. CORD BLOOD MARKET LANDSCAPE
The HSCT Landscape
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age
of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Reimbursement Codes and Reimbursed Amounts for Various Procedures
Associated with HSCTs
The Emerging and Evolving Cord Blood Landscape
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and
Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes
Addressed
Cord Blood TNCs Landscape and Trends
Cord Blood Banking Cost Breakouts
EU and US Cord Blood Transplantation Detailed Cost Breakouts
CHAPTER III. STEM CELL OPPORTUNITIES AND FUNDING SOURCES IN SOME OF THE TOP MARKETS ACROSS THE EUROPEAN UNION
CHAPTER IV. ATMP REGULATORY ROUTES FOR APPROVAL OF CELLULAR THERAPIES IN THE EUROPEAN UNION
APPENDIX I. SELECTED MARKET OPPORTUNITIES IN THE CELLULAR THERAPEUTICS SPACE
APPENDIX II. STEM CELL PUBLICATIONS HOTSPOT MAPPING ANALYSIS
APPENDIX III. RESEARCH METHODOLOGY
Stem Cell Market Segmentation and Industry Structure
Quantitative Trends in the Cellular Therapy and Regenerative Medicine Marketplace
Regenerative Medicine and Stem Cell Research Activity in the US
Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
Breakout of Spending by Companies in the Cellular Therapy/Regenerativi Medicine Space
Breakout of Spending by Product Platforms in Various Spaces
Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
Autologous vs. Allogeneic Cellular Therapy: Industry SWOT Market Timeline
Adult Stem Cell Therapy Quantitative Market Forecast
Stem Cell Research Workflow and Product Development Value Chain
Quantitative Scale of Cellular Therapy Market Opportunities in Various
Disease Classes
Cellular Therapy Product Pipeline
Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell
Type, Therapeutic Areas Addressed, Geography
Companies and Marketed Cellular Therapy Products Currently
CHAPTER II. CORD BLOOD MARKET LANDSCAPE
The HSCT Landscape
HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
Indications for HSCTs in North America: Disease Classes Addressed, Age
of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
Cost Analyses of HSCTs in the EU vs. US Markets
Reimbursement Codes and Reimbursed Amounts for Various Procedures
Associated with HSCTs
The Emerging and Evolving Cord Blood Landscape
Cord Blood Banking Quantitative Market Metrics
Growth of BM, PBL, and CB Units Worldwide in Public Banks and
Registries, Segmented by Country
Cord Blood Transplantation Trends: Age of Recipient, Disease Classes
Addressed
Cord Blood TNCs Landscape and Trends
Cord Blood Banking Cost Breakouts
EU and US Cord Blood Transplantation Detailed Cost Breakouts
CHAPTER III. STEM CELL OPPORTUNITIES AND FUNDING SOURCES IN SOME OF THE TOP MARKETS ACROSS THE EUROPEAN UNION
CHAPTER IV. ATMP REGULATORY ROUTES FOR APPROVAL OF CELLULAR THERAPIES IN THE EUROPEAN UNION
APPENDIX I. SELECTED MARKET OPPORTUNITIES IN THE CELLULAR THERAPEUTICS SPACE
APPENDIX II. STEM CELL PUBLICATIONS HOTSPOT MAPPING ANALYSIS
APPENDIX III. RESEARCH METHODOLOGY
